Szydłowski R, Bodera M, Porwolik H, Porwolik A, Pabis P, Porwolik A, et al. PCSK9 inhibitors – new era of dyslipidemia treatment - effectiveness in reducing low-density lipoprotein (LDL-C) and cardiovascular risk. Qual Sport [Internet]. 2024 Dec. 8 [cited 2025 Jun. 28];36:56299. Available from: https://apcz.umk.pl/QS/article/view/56299